New study results demonstrated the safety and efficacy of the MannKind Afrezza inhaled insulin offering for children with ...

(Nasdaq:GCTK) believes it can tap into a diabetes market that includes millions of people who aren't being served completely.

One of the leaders in continuous glucose monitoring (CGM) technology, Dexcom (Nadsaq:DXCM) continues to expand its ...

It's been a busy couple of years for Tandem Diabetes Care (Nasdaq:TNDM) and it doesn't look like slowing down any time soon.

Sequel Medtech said at the American Diabetes Association's 85th Scientific Sessions that it plans to launch its twiist system ...

Dexcom (Nasdaq:DXCM) has shared a new report highlighting access and attitudes toward type 2 diabetes in the U.S.

A new study showed improved glucose control in pregnant women using Tandem Diabetes Care (Nasdaq:TNDM) insulin delivery ...

Medtronic (NYSE:MDT) today shared data supporting the use of its MiniMed 780G automated insulin delivery system in a range of ...

t:slim X2, meanwhile, is powered by Control-IQ+ technology. Tandem designed the advanced hybrid closed-loop automated insulin ...

A future launch of the dual monitor would only bolster the company’s wide range of diabetes management options. In addition ...

Ypsomed and CamDiab announced that they agreed to integrate their mylife Loop automated insulin delivery system with a future ...